Akebia Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2012
Revenue	187.23	194.62	292.48	211.65	294.64	335	Upgrade
Revenue Growth (YoY)	-30.88%	-33.46%	38.19%	-28.17%	-12.05%	61.26%	Upgrade
Cost of Revenue	65.56	74.15	85.57	150.67	296.48	145.34	Upgrade
Gross Profit	121.66	120.47	206.92	60.98	-1.83	189.67	Upgrade
Selling, General & Admin	100.62	100.23	138.6	174.14	154.1	149.46	Upgrade
Research & Development	53.12	63.08	129.99	147.85	218.49	322.97	Upgrade
Other Operating Expenses	-0.44	0.18	15.93	3.49	3.41	3.53	Upgrade
Operating Expenses	153.31	163.49	284.52	325.48	375.99	475.95	Upgrade
Operating Income	-31.65	-43.02	-77.6	-264.5	-377.83	-286.29	Upgrade
Interest Expense / Income	6.97	6.03	15.69	19.94	8.87	-0.79	Upgrade
Other Expense / Income	4.42	2.87	0.94	-2.41	-1.86	0.79	Upgrade
Pretax Income	-43.03	-51.93	-94.23	-282.02	-384.84	-286.29	Upgrade
Income Tax	0	0	0	0	0	-6.63	Upgrade
Net Income	-43.03	-51.93	-94.23	-282.02	-384.84	-279.66	Upgrade
Shares Outstanding (Basic)	205	187	183	166	138	118	Upgrade
Shares Outstanding (Diluted)	205	187	183	166	138	118	Upgrade
Shares Change	10.93%	2.56%	10.14%	19.85%	16.95%	104.00%	Upgrade
EPS (Basic)	-0.23	-0.28	-0.52	-1.70	-2.78	-2.36	Upgrade
EPS (Diluted)	-0.23	-0.28	-0.52	-1.70	-2.78	-2.36	Upgrade
Free Cash Flow	-25.28	-23.38	-73.27	-253.02	-110.71	-264.1	Upgrade
Free Cash Flow Per Share	-0.12	-0.13	-0.40	-1.52	-0.80	-2.23	Upgrade
Gross Margin	64.98%	61.90%	70.74%	28.81%	-0.62%	56.62%	Upgrade
Operating Margin	-16.90%	-22.10%	-26.53%	-124.97%	-128.23%	-85.46%	Upgrade
Profit Margin	-22.98%	-26.68%	-32.22%	-133.25%	-130.61%	-83.48%	Upgrade
Free Cash Flow Margin	-13.50%	-12.02%	-25.05%	-119.55%	-37.57%	-78.83%	Upgrade
EBITDA	7.34	-4.05	-43.26	-225.96	-343.32	-250.67	Upgrade
EBITDA Margin	3.92%	-2.08%	-14.79%	-106.76%	-116.52%	-74.83%	Upgrade
Depreciation & Amortization	43.41	41.85	35.28	36.13	32.66	36.42	Upgrade
EBIT	-36.06	-45.89	-78.54	-262.09	-375.97	-287.08	Upgrade
EBIT Margin	-19.26%	-23.58%	-26.85%	-123.83%	-127.60%	-85.70%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).